LIMNLiminatus Pharma, Inc. · NASDAQ Global Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

1.00M
Tradeable Now
(estimated float)
1.00M
Effective Supply
33.90M
Fully Diluted
Dilution risk8/10
CONFIDENCE: MEDIUM
HIGHAssessed Aug 21, 2026Trigger: Reverse splitCRITICALPreferred stock conversion overhangCRITICALRapid share count growth

The structure is dominated by a single mechanism: 158,881.1271 Series A Non-Voting Convertible Preferred shares that convert at a fixed 200:1 post-split ratio into 31,776,225 common shares — 23.7x the entire post-split shares outstanding of 1,343,208 and 31.6x the estimated 1,004,538 tradeable float. Conversion requires no payment, so it is not price-sensitive the way a strike-priced instrument is; the only gates are a Nasdaq-mandated stockholder vote (which the company is contractually obligated to pursue and which the recipient affiliates, holding ~19% of the vote, favor) and a resale registration under the 2026-06-29 registration rights agreement. Warrant overhang of 738,686 post-split shares (73% of float) is currently out of the money — the largest tranches are struck at $9.00 versus a $5.16 market — which caps that component, but the company already repriced the February warrants from $0.29 to $0.18 four months after issuance, so the strikes are demonstrably not fixed in practice. Recent issuance activity is severe and continuous: the XBRL delta shows +49.7% shares outstanding in a single quarter (2026-05-14 to 2026-08-14) and +148% over twelve months, driven by a February registered direct, a May warrant exercise, a June inducement, and a July merger issuance. A 1-for-50 reverse split executed 2026-08-21 resets the base and restores enormous authorized headroom against 500,000,000 authorized shares. Score is held at 8 rather than 9-10 only because the preferred conversion is vote-and-registration gated rather than presently exercisable and because no variable-rate or floating-discount convertible is currently outstanding.

Share Structure

Float to Fully Diluted Breakdown

NO DATA

Reported float from Insight Sentry (NASDAQ:LIMN) — 782,657.57 shares; this value is already post-1-for-50-split scale (782,658 x 50 = 39.1M pre-split, consistent with the 2026-03/05 outstanding of 44,877,633 less insiders), so no split rescaling was applied to it. Adjusted based on SEC filing analysis.

Reported Float973K2.9%
Convertible Notes376K1.1%
Related-party short-term loans (Valetudo $450,000, Prophase Sciences $742,500, Hana Immunotherapeutics $50,000, Amantes $200,000) — all past due, repayment deferred by mutual agreement
Conv. Price: unknown
Est. Shares: ~280K (estimate)
Deferred underwriting fee payable to Cantor Fitzgerald ($500,000 unpaid, due 2025-10-27)
Conv. Price: variable
Est. Shares: ~97K (variable-estimate)
Warrants739K2.2%
common207K shares at $9
common207K shares at $9
common193K shares at $9
common102K shares at $575
placement_agent14K shares at $15.95
common17K shares at $575
Other222K0.7%
Float Adjustments222K shares
≈ Estimated Actual Float

Reported float + filing adjustments

1.00M

MEDIUM confidence

Pending Shares as % of Float3,240.6%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted33.90M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits
  • 1-for-50·Aug 21, 2026this month
Active mechanisms
  • Series A Non-Voting Convertible Preferred — 31,776,225 post-split shares at a fixed 200:1 zero-cost ratio, gated only on a Nasdaq stockholder vote the company is obligated to seek
  • Warrant inducement/repricing cycle — the February 2026 warrants were already cut from $0.29 to $0.18 and swapped for 2x new warrants; the same playbook can be re-run on the remaining 738,686 post-split warrant shares
  • Armistice Change of Control Warrants — 206,880 post-split shares with change-of-control economics on top of standard exercise
  • Registration rights overhang — piggy-back and Form S-3 rights under the 2026-06-29 agreement covering ~32.0M post-split shares, none yet registered
  • Settlement-by-share-issuance pattern — Clear Street, Alta Partners, and Cantor Fitzgerald liabilities were all extinguished with stock rather than cash
  • Related-party debt-to-equity conversion precedent — $14,797,901 converted at the Business Combination; $1,942,500 of past-due related-party debt and deferred fees remain

Market Data

Price

$5.16

Market Cap

$6.93M

Outstanding

1.34M

Float

N/A

Avg Volume

1.21M

Exchange: NASDAQ|Source: Insight Sentry